Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
AIDS and Behavior
Erschienen in: AIDS and Behavior 3/2019

24.01.2019 | Original Paper

Multilevel Factors Associated with a Lack of Viral Suppression Among Persons Living with HIV in a Federally Funded Housing Program

verfasst von: Christopher M. Beattie, Ellen W. Wiewel, Yaoyu Zhong, Paul A. Brown, Sarah L. Braunstein, X. Pamela Farquhar, John Rojas

Erschienen in: AIDS and Behavior | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Persons with HIV who are receiving housing services often have high rates of engagement in care, yet many are not virally suppressed. We linked data from the New York City Housing Opportunities for Persons with AIDS (HOPWA) program to electronically reported laboratory tests from the HIV surveillance registry to examine factors associated with a lack of viral suppression. Of 1491 HOPWA consumers, 523 (35.1%) were not durably suppressed, and 253 (17.0%) were unsuppressed at their last viral load test. Substance use, age < 27 years, and emergency housing all independently predicted lack of durable viral suppression and lack of viral suppression at last viral load test.
Literatur
1.
Aidala AA, Wilson MG, Shubert V, Gogolishvili D, Globerman J, Rueda S, et al. Housing status, medical care, and health outcomes among people living with HIV/AIDS: a systematic review. Am J Public Health. 2016;106(1):e1–23.PubMedPubMedCentralCrossRef
2.
Hawk M, Davis D. The effects of a harm reduction housing program on the viral loads of homeless individuals living with HIV/AIDS. AIDS Care. 2012;24(5):577–82.PubMedCrossRef
3.
Kidder DP, Wolitski RJ, Royal S, Aidala A, Courtenay-Quirk C, Holtgrave DR, et al. Access to housing as a structural intervention for homeless and unstably housed people living with HIV: rationale, methods, and implementation of the housing and health study. AIDS Behav. 2007;11(6):149–61.PubMedCrossRef
4.
Terzian AS, Irvine MK, Hollod LM, Lim S, Rojas J, Shepard CW. Effect of HIV housing services on engagement in care and treatment, New York City, 2011. AIDS Behav. 2015;19(11):2087–96.PubMedPubMedCentralCrossRef
5.
Hicks PL, Mulvey KP, Chander G, Fleishman JA, Josephs JS, Korthuis PT, et al. The impact of illicit drug use and substance abuse treatment on adherence to HAART. AIDS Care. 2007;19(9):1134–40.PubMedPubMedCentralCrossRef
6.
Mellins CA, Havens JF, McDonnell C, Lichtenstein C, Uldall K, Chesney M, et al. Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders. AIDS Care. 2009;21(2):168–77.PubMedPubMedCentralCrossRef
7.
Springer SA, Dushaj A, Azar MM. The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: a systematic review. AIDS Behav. 2012;16(8):2119–43.PubMedPubMedCentralCrossRef
8.
Torian LV, Xia Q, Wiewel EW. Retention in care and viral suppression among persons living with HIV/AIDS in New York City, 2006–2010. Am J Public Health. 2014;104(9):e24–9.PubMedPubMedCentralCrossRef
9.
Zanoni BC, Mayer KH. The adolescent and young adult HIV cascade of care in the United States: exaggerated health disparities. AIDS Patient Care STDs. 2014;28(3):128–35.PubMedPubMedCentralCrossRef
10.
Leaver CA, Bargh G, Dunn JR, Hwang SW. The effects of housing status on health-related outcomes in people living with HIV: a systematic review of the literature. AIDS Behav. 2007;11(6):85–100.PubMedCrossRef
11.
Drobnik A, Pinchoff J, Bushnell G, Ly S, Yuan J, Varma JK, et al. Matching HIV, tuberculosis, viral hepatitis, and sexually transmitted diseases surveillance data, 2000–2010: identification of infectious disease syndemics in New York City. J Public Health Manag Pract. 2014;20(5):506–12.PubMed
12.
Xia Q, Wiewel EW, Braunstein SL, Kersanske LS, Torian LV. Comparison of indicators measuring the proportion of human immunodeficiency virus-infected persons with a suppressed viral load. Ann Epidemiol. 2015;25(4):226–30.PubMedCrossRef
13.
Crepaz N, Tang T, Marks G, Mugavero MJ, Espinoza L, Hall HI. Durable viral suppression and transmission risk potential among persons with diagnosed HIV infection: United States, 2012–2013. Clin Infect Dis. 2016;63(7):976–83.PubMedPubMedCentralCrossRef
14.
Xia Q, Robbins RS, Lazar R, Torian LV, Braunstein SL. Racial and socioeconomic disparities in viral suppression among persons living with HIV in New York City. Ann Epidemiol. 2017;27(5):335–41.PubMedCrossRef
15.
Towe V, Wiewel E, Zhong Y, Beattie C, Johnson R, Farquhar X, Rojas J. Stable housing placement and viral suppression after rapid rehousing for homeless persons with HIV: Data for action from the Enhanced Housing Placement Assistance randomized control trial in NYC. Poster session presented at: The North American Housing and HIV Research Summit IX; 2018 August 1–2; San Francisco.
16.
Nance RM, Delaney JAC, Simoni JM, Wilson IB, Mayer KH, Whitney BM, et al. HIV viral suppression trends over time among HIV-infected patients receiving care in the United States, 1997 to 2015: a cohort study. Ann Intern Med. 2018;169:376–84.PubMedPubMedCentralCrossRef
17.
Brown MJ, Serovich JM, Laschober TC, Kimberly JA. Age and racial disparities in substance use and self-reported viral suppression among men who have sex with men with HIV. Int J STD & AIDS. 2018;29:1174–82.CrossRef
18.
Doshi RK, Milberg J, Jumento T, Matthews T, Dempsey A, Cheever LW. For many served by the Ryan white HIV/AIDS program, disparities in viral suppression decreased, 2010–2014. Health Aff (Proj Hope). 2017;36(1):116–23.CrossRef
19.
Crepaz N, Dong X, Wang X, Hernandez AL, Hall HI. Racial and ethnic disparities in sustained viral suppression and transmission risk potential among persons receiving HIV care-United States, 2014. MMWR Morb Mortal Wkly Rep. 2018;67(4):113–8.PubMedPubMedCentralCrossRef
20.
Feller DJ, Agins BD. Understanding determinants of racial and ethnic disparities in viral load suppression. J Int Assoc Provid AIDS Care. 2017;16(1):23–9.PubMedCrossRef
21.
Wiewel EW, Bocour A, Kersanske LS, Bodach SD, Xia Q, Braunstein SL. The association between neighborhood poverty and HIV diagnoses among males and females in New York City, 2010–2011. Public health reports (Washington, DC: 1974). Public Health Rep. 2016;131(2):290–302.PubMedPubMedCentralCrossRef
22.
Marcus AF, Echeverria SE, Holland BK, Abraido-Lanza AF, Passannante MR. How neighborhood poverty structures types and levels of social integration. Am J Community Psychol. 2015;56(1–2):134–44.PubMedCrossRef
23.
Sullivan BJ, Burke J. Single-room occupancy housing in New York City: the origins and dimensions of a crisis. CUNY Law Rev. 2013;17(1):113–43.CrossRef
24.
Katz IT, Ryu AE, Onuegbu AG, Psaros C, Weiser SD, Bangsberg DR, et al. Impact of HIV-related stigma on treatment adherence: systematic review and meta-synthesis. J Int AIDS Soc. 2013;16(2):18640.PubMedPubMedCentralCrossRef
25.
Parker R, Aggleton P. HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action. Soc Sci Med. 2003;57(1):13–24.PubMedCrossRef
26.
Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav. 2009;13(6):1160–77.PubMedPubMedCentralCrossRef
27.
Stack CB. All our kin: strategies for survival in a black community. New York, NY: Basic Books; 2003.
28.
Desmond M. Disposable ties and the urban poor. Am J Sociol. 2012;117(5):1295–335.CrossRef
29.
Himelhoch S, Brown CH, Walkup J, Chander G, Korthius PT, Afful J, et al. HIV patients with psychiatric disorders are less likely to discontinue HAART. AIDS. 2009;23(13):1735–42.PubMedPubMedCentralCrossRef
30.
Harrison L. The validity of self-reported drug use in survey research: an overview and critique of research methods. NIDA Res Monogr. 1997;167:17–36.PubMed
Metadaten
Titel
Multilevel Factors Associated with a Lack of Viral Suppression Among Persons Living with HIV in a Federally Funded Housing Program
verfasst von
Christopher M. Beattie
Ellen W. Wiewel
Yaoyu Zhong
Paul A. Brown
Sarah L. Braunstein
X. Pamela Farquhar
John Rojas
Publikationsdatum
24.01.2019
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 3/2019
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-019-02399-7

Weitere Artikel der Ausgabe 3/2019

AIDS and Behavior 3/2019 Zur Ausgabe

Substantive Review

Self-Stigma Reduction Interventions for People Living with HIV/AIDS and Their Families: A Systematic Review

Original Paper

Mediating Effects of Depressive Symptoms on Perceived Social Support and HIV Disclosure: Assessing Moderation by Sex

Original Paper

Depressive Symptoms at HIV Testing and Two-Year All-Cause Mortality Among Men Who Inject Drugs in Vietnam

Original Paper

Correlates of Fatigue Among South African Adolescents Living with HIV and Receiving Antiretroviral Therapy

Original Paper

Supportive Housing Promotes AIDS-Free Survival for Chronically Homeless HIV Positive Persons with Behavioral Health Conditions

Correction

Correction to: Experienced HIV-Related Stigma and Psychological Distress in Peruvian Sexual and Gender Minorities: A Longitudinal Study to Explore Mediating Roles of Internalized HIV-Related Stigma and Coping Styles

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

NSCLC: Progressionsfreies Überleben unter Osimertinib fast versiebenfacht

06.06.2024 ASCO 2024 Kongressbericht

Erste Ergebnisse der Phase-III-Studie LAURA etablieren Osimertinib als neuen Therapiestandard für Menschen mit nicht-resezierbarem, EGFR-mutiertem, nicht-kleinzelligem Lungenkarzinom im Stadium III, die nach definitiver Radiochemotherapie progressionsfrei sind. Auf der ASCO-Tagung wurden diese beeindruckenden Ergebnisse besprochen.

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gute molekulare Response, aber seltener ernste Nebenwirkungen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise